Rapport Therapeutics, Inc. financial statements
Rapport Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 111.48M | 10-K |
| Cash and equivalents | USD 52.65M | 10-Q |
| Total debt | USD 11.48M | EODHD |
Rapport Therapeutics, Inc. financials on 6ix · Rapport Therapeutics, Inc. on 6ix